SCHEMBL21614697

SCHEMBL21614697

CC(C)Oc1ccc(-c2ncc(CNc3cc(C#N)nc(C(F)(F)F)c3)s2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ KCNH2 Q12809 1/20 0.55
▸ ALPL P05186 2/20 0.35
▸ ALPI P09923 2/20 0.35
▸ MAPT P10636 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ TP53 P04637 2/20 0.34
▸ HDAC3 O15379 2/20 0.34
▸ HDAC1 Q13547 2/20 0.34
▸ HDAC6 Q9UBN7 2/20 0.34
▸ FFAR1 O14842 1/20 0.34
▸ S1PR1 P21453 2/20 0.33
▸ S1PR5 Q9H228 2/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30062257 0.90 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2ALPLALPI
SCHEMBL23611318 0.90 CYP2C19 (0.51) CYP2C19CYP2C9KCNH2ALPLALPI
SCHEMBL21614737 0.88 CYP2C19 (0.73) CYP2C19CYP2C9KCNH2S1PR1S1PR5
SCHEMBL21612040 0.87 CYP2C19 (0.61) CYP2C19CYP2C9KCNH2ALPLALPI
SCHEMBL21614772 0.84 CYP2C19 (0.75) CYP2C19CYP2C9KCNH2HDAC3HDAC1
SCHEMBL23611317 0.82 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2ALPLALPI
SCHEMBL30060450 0.82 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2ALPLALPI
SCHEMBL23611535 0.82 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2ALPLALPI
SCHEMBL30060458 0.82 CYP2C19 (0.52) CYP2C19CYP2C9KCNH2ALPLALPI
SCHEMBL31694534 0.81 CYP2C19 (0.53) CYP2C19CYP2C9KCNH2TP53HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 CYP2C19 1824/4885CYP2C9 2997/4885KCNH2 2343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback